Synonym: (+)-Medetomidine hydrochloride; (S)-Medetomidine hydrochloride; 4-[(S)-α,2,3-Trimethylbenzyl]imidazole monohydrochloride; 5-[(1S)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole hydrochloride
CAS Number: 145108-58-3
Empirical Formula (Hill Notation): C13H16N2 · HCl
Molecular Weight: 236.74
MDL Number: MFCD07772269
Linear Formula: C13H16N2 · HCl
Product Type: Chemical
| API family |
dexmedetomidine, medetomidine |
| application(s) |
pharmaceutical (small molecule) |
| format |
neat |
| grade |
pharmaceutical primary standard |
| InChI |
1S/C13H16N2.ClH/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13;/h4-8,11H,1-3H3,(H,14,15);1H/t11-;/m0./s1 |
| InChI key |
VPNGEIHDPSLNMU-MERQFXBCSA-N |
| manufacturer/tradename |
USP |
| SMILES string |
[Cl-].[N+H2]1C=NC=C1[C@@H](C)c2c(c(ccc2)C)C |
| Analysis Note: |
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: |
Dexmedetomidine hydrochloride USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monograph such as Dexmedetomidine Injection |
| Biochem/physiol Actions: |
Dexmedetomidine hydrochloride is a highly potent and selective α2-adrenergic agonist with analgesic and sedative properties, the (+)-isomer of medetomidine. Dexmedetomidine hydrochloride is used clinically as an anesthetic agent to reduce anxiety and tension and promote relaxation and sedation without causing respiratory depression. |
| Biochem/physiol Actions: |
Dexmedetomidine hydrochloride is a highly potent and selective α2-adrenergic agonist with analgesic and sedative properties. |
| General description: |
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia   . |
| Other Notes: |
Sales restrictions may apply. |
GHS07